MyMedEx Launches Global AI Health Platform for Farsi Speakers

Tallinn, Estonia - August 2025
MedExFuture OÜ, an Estonian-based digital health startup, proudly announces the launch of MyMedEx.ai, a revolutionary platform that redefines access to personalized healthcare services for over 25 million Farsi-speaking individuals worldwide. Combining the power of AI, telemedicine, and genetic lifestyle profiling, MyMedEx offers tailored medical support beyond the limits of traditional hospitals.

"We originally envisioned it as an 'AI Hospital'," says Mehdi Raufi, Co-Founder and Chief Innovation Officer of MedExFuture. "But we quickly realized that it's far beyond a hospital - it's an AI infrastructure capable of hosting thousands of real, physical hospitals within its ecosystem."

The platform empowers users to begin their health journey with Dr. Bot, an advanced multilingual AI assistant. This assistant provides preliminary health support, lifestyle advice, and connects users to verified Farsi-speaking physicians across the globe. Through AI-powered matchmaking and genomic insights, MyMedEx personalizes every step - from prevention to treatment.

"Farsi-speaking users abroad often face high medical costs, insurance limitations, and language barriers," Raufi adds. "We created MyMedEx to fix this - to deliver affordable, customized, AI-backed care in their native language, no matter where they live."

In addition to the AI experience, MyMedEx integrates telemedicine, real-time doctor access, and personalized treatment plans based on NGS genetic testing via its GenEx system. Moreover, its medical tourism division - MedExTour - facilitates high-end physical treatment options for Persian speakers in top global clinics.

Key features of MyMedEx include:
- AI-powered assistant "Dr. Bot" for first-level triage
- Verified Iranian doctors with global availability
- Personalized health plans using genomic (NGS) data
- Smart lifestyle and diet recommendations (via AgeX)
- Multilingual telemedicine with live interpretation
- Affordable healthcare access for uninsured expats
- Contracts with hospitals for personalized treatment abroad

MedExFuture remains self-funded and built on proprietary AI to minimize operational costs. Plans for global expansion include Arabic and Turkic language versions in the near future.

"We've built this platform from scratch without external funding, and our goal is to empower both patients and doctors," says Raufi. "We will soon offer pre-funding equity shares to physicians and reach one million users by 2028."

MyMedEx is now live and accessible via https://MyMedEx.ai.

Valukoja 8/2, C Corpus,
11415 Tallinn, Estonia

MedExFuture OÜ is an Estonia-based digital health startup building AI-powered solutions for genomic, personalized, and cross-border healthcare. Its flagship platform, MyMedEx.ai, empowers Farsi-speaking individuals with personalized medicine, real-time doctor access, and genomic lifestyle optimization.

This release was published on openPR.